Mitigating the impact of COVID-19
There is an urgent need to develop breakthrough treatments for men with prostate cancer, and research is how we will achieve this. The COVID-19 pandemic has increased the urgency by causing significant delays to cancer diagnosis and treatment.
We supported our scientists throughout the pandemic, in addition to running a new grant call to provide a funding opportunity during a period when there was little available.
As prostate cancer patients are at higher risk from COVID-19, we worked hard to quickly provide information to prostate cancer patients regarding their health and safety in the pandemic. We published a patient story from a gentleman who attended a hospital appointment during the pandemic to reassure other patients about safety measures.
We also ran a survey to better understand patient experiences and plan to use this information to build better patient information programs.
4 Zoom calls, with appearances by 7 scientists and attended by 126 patients and supporters
37 men with prostate cancer engaged in an online research community led by two experienced researchers for 14 days
28 patient panelists reviewed our 2020 shortlist and helped us decide what new research to fund in 2021